- Home
- Applications
- pancreas cancer
Show results for
Refine by
Pancreas Cancer Product Applications
6 applications found
Like other nanocarriers, synthetic exosomes can be used to treat different types of cancer successfully, by encapsulating the desired anti-tumoral drug or RNA and enzymes. Several studies have used engineered exosomes from dendritic or macrophage cells to release chemotherapeutic compounds as doxorubicin, paclitaxel miRNA or siRNA to induce antitumoral activity. Rodent mammary carcinoma, mice lung cancer, glioma and pancreatic cancer are just some targeted diseases in preclinical testing using exosome delivery ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Longitudinal imaging of pancreatic cancer. Monitor in a minimally invasive manner both tissue morphology and fibrosis (fluorescein) and cathepsin activity (Prosense® 680). A very thin probe (S 650) was used to monitor the pancreas of the same mouse over 9 months. ...
ByMauna Kea Technologies based in Paris, FRANCE
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
ByAscelia Pharma AB based in Malmö, SWEDEN
The Symbios TPR4000™ has great promise in the field of healthcare beyond its obvious benefits in the manufacture of pharmaceuticals and the treatment of the waste stream that results from the manufacturing process. While these healthcare applications will likely require an FDA approval process, Symbios is partnering with leaders in their respective fields to navigate through the required regulatory approval ...
BySymbios Technologies LLC. based in Fort Collins, COLORADO (USA)
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
Surgery isn’t an option for every patient diagnosed with pancreatic cancer. But with the IntraOp® Mobetron® and electron IORT, more patients than ever before are eligible. And we know that those who are treated surgically have a higher chance of ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)